Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
How is AI developing in pharmacovigilance? | Synapse
March 3, 2026
Open Access
How is AI developing in pharmacovigilance?
AB
Andrew Bate
London School of Hygiene & Tropical Medicine
PT
Philip Tregunno
Puntos clave
AI plays a crucial role in pharmacovigilance, improving detection of adverse events through data mining and predictive analytics.
The analysis shows a significant increase in adverse event reporting efficiency when utilizing artificial intelligence technologies.
Approach includes leveraging various data sources to enhance pharmacovigilance processes, emphasizing real-time safety monitoring.
This highlights the potential for AI to significantly improve drug safety protocols, needing further implementation studies.
Leer artículo completo
externamente
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo
Cite This Study
Copy
Bate et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75f4dc6e9836116a2a946
https://doi.org/https://doi.org/10.1177/20420986251412773
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo